Nemesis Bioscience is a biopharmaceutical company developing Nemesis Symbiotics© - DNA therapeutics administered before antibiotics to inactivate resistance in bacterial pathogens. These Nemesis Symbiotics© will make existing antibiotics work again, prevent the spread of resistance genes and so also protect the efficacy of new antibiotics. The technology is applicable to all antibiotic classes, all known resistance mechanisms and all bacteria. Other applications include reduction of chemotherapeutic toxicity, inactivation of virulence factors and in vivo synthesis of biofuels and therapeutics. The company was awarded the King’s College, Cambridge Entrepreneurship Award for 2014 and has filed patent applications internationally on its inventions. NEMESIS BIOSCIENCE LTD is a biotechnology company based on th Babraham Research Campus, Cambridge, CB22 3AT, UK
View Top Employees from NEMESIS BIOSCIENCE LTDWebsite | http://www.nemesisbio.com |
Revenue | $5.6 million |
Employees | 5 (3 on RocketReach) |
Founded | 2014 |
Phone | +44 1223 804075 |
Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
Industry | Biotechnology, Business Services General, Biopharma, Business Services, Drug Discovery, Health Care, Science and Engineering, Medical, Pharmaceutical |
Competitors | Babraham Research Campus, Core Precision, Elasmogen Ltd, ImmuPharma PLC, ImmunoBiology Limited |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies |
Looking for a particular NEMESIS BIOSCIENCE LTD employee's phone or email?
The NEMESIS BIOSCIENCE LTD annual revenue was $5.6 million in 2024.
Frank Massam is the CEO of NEMESIS BIOSCIENCE LTD.
3 people are employed at NEMESIS BIOSCIENCE LTD.
The NAICS codes for NEMESIS BIOSCIENCE LTD are [5417, 54171, 54, 541714, 541].
The SIC codes for NEMESIS BIOSCIENCE LTD are [87, 873].